159 related articles for article (PubMed ID: 31338323)
1. Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells.
Neves SP; de Carvalho NC; da Silva MM; Rodrigues ACBC; Bomfim LM; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Batista AA; Bezerra DP
Front Oncol; 2019; 9():562. PubMed ID: 31338323
[TBL] [Abstract][Full Text] [Related]
2. Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.
D'Sousa Costa CO; Araujo Neto JH; Baliza IRS; Dias RB; Valverde LF; Vidal MTA; Sales CBS; Rocha CAG; Moreira DRM; Soares MBP; Batista AA; Bezerra DP
Oncotarget; 2017 Nov; 8(61):104367-104392. PubMed ID: 29262647
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.
Bomfim LM; de Araujo FA; Dias RB; Sales CBS; Rocha CAG; Correa RS; Soares MBP; Batista AA; Bezerra DP
Sci Rep; 2019 Aug; 9(1):11483. PubMed ID: 31391500
[TBL] [Abstract][Full Text] [Related]
4. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model.
Baliza IRS; Silva SLR; Santos LS; Neto JHA; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Batista AA; Bezerra DP
Front Oncol; 2019; 9():582. PubMed ID: 31334116
[TBL] [Abstract][Full Text] [Related]
6. A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway.
de Carvalho NC; Neves SP; Dias RB; Valverde LF; Sales CBS; Rocha CAG; Soares MBP; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
Cell Death Dis; 2018 Jan; 9(2):79. PubMed ID: 29362398
[TBL] [Abstract][Full Text] [Related]
7. Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling.
Silva SLR; Baliza IRS; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Correa RS; Batista AA; Bezerra DP
Sci Rep; 2019 Jul; 9(1):11094. PubMed ID: 31366902
[TBL] [Abstract][Full Text] [Related]
8. Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells.
de Souza Oliveira M; de Santana ÁAD; Correa RS; Soares MBP; Batista AA; Bezerra DP
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848969
[TBL] [Abstract][Full Text] [Related]
9. Antiparasitic activities of novel ruthenium/lapachol complexes.
Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
[TBL] [Abstract][Full Text] [Related]
10. A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells.
Silva VR; Corrêa RS; Santos LS; Soares MBP; Batista AA; Bezerra DP
Sci Rep; 2018 Jan; 8(1):288. PubMed ID: 29321581
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
[TBL] [Abstract][Full Text] [Related]
12. Xylopine Induces Oxidative Stress and Causes G
Santos LS; Silva VR; Menezes LRA; Soares MBP; Costa EV; Bezerra DP
Oxid Med Cell Longev; 2017; 2017():7126872. PubMed ID: 29362667
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
14. A Novel Ruthenium(II) Complex With Lapachol Induces G2/M Phase Arrest Through Aurora-B Kinase Down-Regulation and ROS-Mediated Apoptosis in Human Prostate Adenocarcinoma Cells.
De Grandis RA; Oliveira KM; Guedes APM; Dos Santos PWS; Aissa AF; Batista AA; Pavan FR
Front Oncol; 2021; 11():682968. PubMed ID: 34249731
[TBL] [Abstract][Full Text] [Related]
15. Tingenone and 22-hydroxytingenone target oxidative stress through downregulation of thioredoxin, leading to DNA double-strand break and JNK/p38-mediated apoptosis in acute myeloid leukemia HL-60 cells.
Rodrigues ACBDC; Bomfim LM; Neves SP; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Costa EV; da Silva FMA; Rocha WC; Koolen HHF; Bezerra DP
Biomed Pharmacother; 2021 Oct; 142():112034. PubMed ID: 34411914
[TBL] [Abstract][Full Text] [Related]
16. The trans-[Ru(PPh
Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
[TBL] [Abstract][Full Text] [Related]
17. A novel platinum complex containing a piplartine derivative exhibits enhanced cytotoxicity, causes oxidative stress and triggers apoptotic cell death by ERK/p38 pathway in human acute promyelocytic leukemia HL-60 cells.
Oliveira MS; Barbosa MIF; de Souza TB; Moreira DRM; Martins FT; Villarreal W; Machado RP; Doriguetto AC; Soares MBP; Bezerra DP
Redox Biol; 2019 Jan; 20():182-194. PubMed ID: 30359932
[TBL] [Abstract][Full Text] [Related]
18. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
[TBL] [Abstract][Full Text] [Related]
19. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
[TBL] [Abstract][Full Text] [Related]
20. cis-[RuCl(BzCN)(bipy)(dppe)]PF6 induces anti-angiogenesis and apoptosis by a mechanism of caspase-dependent involving DNA damage, PARP activation, and Tp53 induction in Ehrlich tumor cells.
Magalhães LF; Mello-Andrade F; Pires WC; Silva HD; da Silva PFF; Macedo LM; Henrique de Castro C; Carneiro CC; Cardoso CG; de Melo Reis PR; Camargo de Oliveira L; Caetano RR; Batista AA; Silveira-Lacerda EP
Chem Biol Interact; 2017 Dec; 278():101-113. PubMed ID: 28935426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
